GRAMON exports 10 trademarks, in different presentations, to customers distributed in 13 countries, for an annual amount exceeding US$ 3,000,000.
The main product is Synthetic Calcitonin - salmon, nasal spray, with which Gramon's licensees have achieved a leading position in markets such as Brazil, Mexico, Turkey, Colombia, Peru, Paraguay, Venezuela, Uruguay, Guatemala and other Central American countries.

GRAMON in Uruguay:

GRAMON was founded in 1931 and is positioned among the country's 10 leading companies.
In 1992, the strategic alliance between GRAMON Laboratories and Bagó created a new company, GRAMON BAGO de URUGUAY S.A., which presently ranks 5th within the Uruguayan market with a commercial turnover of US$ 13,000,000 and a 4% total market share.
This company markets GRAMON and BAGO lines, and represents Falk (Germany). Its manufacturing facility - committed to serving both the local and export markets - presently employs 145 persons.

GRAMON in Paraguay:

Founded in 1972, the company is in the 5th position within the market with a commercial turnover of about US$ 6,000,000 and a total market share of 4%.
It produces and distributes specialties, exports and represents FALK (Alemania) , Serono (Italy), Bristol Myers for over-the-counter products, Heno de Pravia (Spain) for toiletries and fragrances, and Falk (Germany).
The organization is staffed by 110 persons.

GRAMON in Bolivia:

Founded in La Paz in 1970, this company ranks 11 within the Bolivian market, is undergoing a marked growth and participates with a market share of 2%. In addition, it represents Serono (Italy). The company presently employs 35 persons.